Abstract
Current serologic tests used to detect antibodies to Neospora caninum require species-specific secondary antibodies, limiting the number of species that can be tested. In order to examine a wide variety of animal species that may be infected with N. caninum, a modified direct agglutination test (N-MAT) similar to the Toxoplasma gondii modified direct agglutination test (T-MAT) was developed. This test measures the direct agglutination of parasites by N. caninum-specific antibodies in serum, thus eliminating the need for secondary host-specific anti-isotype sera. The N-MAT was compared to the indirect fluorescent-antibody test (IFAT) and the enzyme-linked immunosorbent assay (ELISA) with a “gold standard” serum panel from species for which secondary antibodies were available (n = 547). All positive samples tested were from animals with histologically confirmed infections. Up to 16 different species were tested. The N-MAT gave a higher sensitivity (100%) and specificity (97%) than the ELISA (74 and 94%, respectively) and had a higher sensitivity but a lower specificity than the IFAT (98 and 99%, respectively). The reduced specificity of the N-MAT was due to false-positive reactions in testing fetal fluids with particulate matter or severely hemolyzed serum. Overall, the N-MAT proved to be highly sensitive and specific for both naturally and experimentally infected animals, highly reproducible between and within readers, easy to use on large sample sizes without requiring special equipment, and useful in testing serum from any species without modification.
Neospora caninum is a pathogenic protozoan that was first identified in 1988 as a new genus of Toxoplasma-like apicomplexan. Although first associated with congenital encephalomyelitis in puppies (20, 21), it has since been described for cattle, sheep, goats, and horses (18). It is very similar to Toxoplasma gondii in morphology and biological behavior, but its antigenic and ultrastructural characteristics differ (7, 20, 21). N. caninum has been found to be the major cause of bovine abortion in the United States (2), New Zealand (45), The Netherlands (53), and Great Britain (49). Abortions resulting from N. caninum infections are also recognized in several other countries (4). Approximately 42% of abortions in California dairy cattle alone have been attributed to N. caninum infection (3).
The host range and life cycle of N. caninum remain unknown (7). To date, the only known mode of transmission is vertical transmission, whereby the parasite passes transplacentally from an infected dam to her offspring (5). Because of its similarities to T. gondii, N. caninum is thought to possess a similar life cycle with horizontal transmission via the ingestion of coccidial oocysts shed in the feces of the unknown definitive host (8). Recent evidence of a point source exposure to N. caninum in dairies in South Dakota (54) and California (40) is consistent with the assumption that N. caninum is spread horizontally by a definitive host. In both instances, exposure to the organism was thought to be through contaminated feed which was incorporated into a total mixed ration. Another study gave evidence for congenital transmission in an N. caninum-endemic herd but found that most cows aborting during an epidemic were infected postnatally (48).
Currently, there is no effective means for treatment or control of this disease, particularly in dairies where bovine neosporosis is a major disease problem (8, 47). Culling of seropositive cows is the only current means of control (47), and this may or may not be beneficial depending on several factors, such as the risk of horizontal transmission, the reproductive history and costs and benefits of culling each animal, and the herd seroprevalence. Implementation of more effective control procedures would be facilitated by the identification of the definitive host(s) for N. caninum. To date, the definitive host is completely unknown. One study suggested that, as for T. gondii, cats might also be the definitive host for N. caninum (1). However, this proposal has not been supported by other investigators (19, 39). Results of laboratory and field studies looking at dogs, cats, rats, and mice have all proved negative (11a), suggesting that the definitive host may be some other wildlife species. If so, finding this definitive host will be extremely difficult without some methodology to screen various wildlife species for evidence of exposure to the N. caninum protozoan.
The purpose of this study was to develop and evaluate a modified agglutination test (MAT) that could be used to screen for antibodies to N. caninum (N-MAT) in a wide variety of wildlife species suspected of being possible definitive hosts for the parasite. Unlike most serologic tests, the agglutination test does not require species-specific conjugates, and so any animal species could conceivably be tested for the presence of N. caninum antibodies. Direct agglutination (DA) is based on the principle that formalin-treated organisms agglutinate in the presence of specific immunoglobulin G (IgG) antibodies (28). A Toxoplasma DA test was first described by Fulton et al. (27–29) and then modified and adapted by Desmonts and Remington (17) to improve the sensitivity and specificity. Today, the modified DA test for T. gondii (T-MAT) is widely used for research purposes in all species and as a screening test for humans in Europe (17, 33, 41, 52). The test is rapid and easy to perform, does not require sophisticated equipment, and can be performed on sera from any species without modification (6, 17, 27, 29, 33, 44, 52). Such a test could be used in extensive seroprevalence studies to help pinpoint possible definitive hosts for N. caninum, particularly for those species found in dairies with endemic N. caninum infection. This would in turn allow for the development and implementation of proper preventative measures against N. caninum.
In this study, N. caninum antigen was prepared and testing conditions were optimized for the development of the N-MAT. In order to determine the diagnostic capabilities of the test, an extensive panel of “gold standard” sera from histologically confirmed infected and uninfected animals was used to compare results to those obtained from the more commonly used indirect fluorescent-antibody test (IFAT) and the enzyme-linked immunosorbent assay (ELISA).
MATERIALS AND METHODS
MAT antigen preparation and testing methods.
The N. caninum isolate (BPA-1) was obtained from an aborted bovine fetus (15) and maintained in vitro on a stationary monolayer of Vero (green monkey kidney) cells. Tachyzoites were harvested when ≥80% of the Vero cells were infected. The monolayer was dislodged from the flask into the cell culture medium with a cell scraper (Costar Corp., Cambridge, Mass.). This suspension was then centrifuged at 1,500 × g for 10 min, the supernatant was discarded, and the pellet was resuspended in 2 to 3 ml of filtered (0.2-μm pore size; Gelman Sciences, Ann Arbor, Mich.) phosphate-buffered saline (PBS; pH 7.4). The resulting suspension was put through a PD-10 Sephadex column (Pharmacia Biotech, Uppsala, Sweden) to reduce Vero cell contamination and centrifuged at 1,500 × g for 10 min, the supernatant was discarded, and the pellet was resuspended in 1 ml of filtered PBS. A 1:100 dilution was made to count the parasites on a hemocytometer. The remaining suspension was again centrifuged at 1,500 × g for 10 min, the supernatant was decanted, and the pellet was resuspended in 2 to 3 ml of 37% formaldehyde solution (Fisher Scientific, Pittsburgh, Pa.) diluted with filtered PBS to 6%. This formalin suspension of parasites was then stored overnight at 4°C to fix the parasites. The next day, the formalin suspension was centrifuged at 1,500 × g for 10 min and washed three times with filtered PBS. After the last wash, the pellet was resuspended in alkaline buffer (7.02 g of NaCl, 3.09 g of H3BO3, 24 ml of 1 N NaOH, 4 g of horse serum [HS] albumin [fraction V], 50 mg of eosin Y, dH2O to 1 liter, 0.1% sodium azide as a preservative; pH 8.7) to a final concentration of tachyzoites between 30,000 and 40,000/μl. Eosin Y was added to the antigen for ease of reading results. The final parasitic antigen suspension was stored at 4°C. The T. gondii antigen suspension can be kept at this temperature for up to 1 year without loss of reactivity (17), and the same holds true for the N-MAT antigen suspension as determined by using stored antigen at various monthly time points without seeing any change in results from samples previously tested.
Each serum sample was first rapidly screened with two wells in a U-bottom microtiter plate (Dynatech Laboratories, Inc., Chantilly, Va.). The serum was diluted with PBS 1:20 in the first well and 1:2,000 in the second well. Twenty-five microliters of 0.2 M 2-mercaptoethanol (diluted in PBS) was added to each well, bringing the serum to a final dilution of 1:40 and 1:4,000 respectively. The 1:4,000 well acted as a control to monitor for a prozone effect. Fifty microliters of antigen suspension was added to each well. Two wells were reserved for positive and negative controls. The positive control well contained serum from a heifer experimentally inoculated with tachyzoites of the BPA-1 N. caninum isolate previously described, and the negative control well contained PBS with no serum added. The wells were then mixed thoroughly by pipetting them up and down several times, covered, and incubated overnight at 37°C with 5% CO2. The results were read the next day. Diffuse opacity across the entire diameter of the well was regarded as a positive agglutination reaction, whereas a negative well exhibited a central discrete opaque dot or button. Following this initial rapid screen, an endpoint titration was set up for any sample with a positive reaction at 1:40 with twofold serial dilutions from 1:40 to 1:20,480. Mercaptoethanol and antigen were then added to all wells as described above. The endpoint titer was determined by using the dilution in the last well which showed a positive reaction.
IFAT antigen preparation and testing methods.
The IFAT was performed as previously described (14) with antigen slides (Cell Line Associates, Newfield, N.J.) that were prepared with tachyzoites of the BPA-1 N. caninum isolate. The fluorescein isothiocyanate-labeled, affinity-purified antibodies directed against species-specific IgG were diluted 1:300 for bovine antisera (Jackson ImmunoResearch, Inc., West Grove, Pa.) and 1:100 for monkey, dog (used for both domestic dog and coyote), rabbit, cat (used for both domestic cat and mountain lion), rat, mouse, horse, goat, and chicken antisera (all from Jackson ImmunoResearch, except for monkey antisera, which were from Sigma, St. Louis, Mo.) in PBS and added in 10-μl aliquots to each well. For testing pigeon serum, an unconjugated pigeon serum (Nordic Immunology, Tilburg, The Netherlands) directed against IgG was used with a fluorescein-labeled rabbit antibody (Jackson ImmunoResearch) as a tertiary antibody. A fluorescein isothiocyanate-conjugated polyclonal anti-psittacine Ig antibody produced by immunization of a rabbit with ammonium sulfate-precipitated psittacine serum from multiple psittacine species (kindly provided by C. Cray, University of Miami School of Medicine) was used as the conjugating antibody for all bird samples (blackbirds, starlings, and budgerigars) for which a secondary antibody was not commercially available. The bird conjugate was diluted 1:10 in PBS and added to the slides in 10-μl aliquots for each well. The endpoint titer was the last serum dilution showing distinct, whole-parasite fluorescence (14).
ELISA antigen preparation and testing methods.
The whole-parasite lysate ELISA was performed as previously described (26) with a few modifications. Briefly, plates were coated with supernatant antigens from sonicated (Heat Systems Ultrasonic Processor) tachyzoites for 2 h at 37°C, washed with PBS–0.05%-Tween (PBS-T), and blocked with 200 μl of 5% heat-inactivated HS in PBS-T for 1 h at 37°C. Plates were then rinsed and dried completely before being stored at 4°C. Prior to use, test samples were diluted 1:100 in PBS-T containing 1% heat-inactivated HS. The plates were incubated for 30 min at 37°C with 100 μl of sample per well and then washed four times with PBS-T. Peroxidase-labeled rabbit anti-bovine IgG (Jackson ImmunoResearch) was diluted 1:5,000 in PBS-T containing 1% heat-inactivated HS, and 100-μl aliquots were incubated for 30 min at 37°C in the wells. The plates were washed a final four times with PBS-T and developed with 100 μl of ABTS [2,2′-azinobis(3-ethylbenzothiazoline)-6 sulfonic acid diammonium salt]–1-Step (Pierce, Rockford, Ill.) for 30 min at room temperature. The reaction was stopped with 100 μl of 1% sodium dodecyl sulfate, and the optical density (OD) was determined at a wavelength of 405 nm with a reference wavelength of 490 nm. Final ODs were obtained by subtracting the OD values of the samples from the OD values of the blanks (1% heat-inactivated HS in PBS-T, with no test serum added). Since bovine samples were the only samples that could be run on this ELISA, the same bovine serum samples used by Louie et al. (34) were used to compare this ELISA with the IFAT and MAT (34).
Gold standard panel.
Confirmed N. caninum-positive animals were defined as animals experimentally infected with live parasites (tachyzoites or bradyzoites) and naturally infected animals confirmed as infected by postmortem examination of tissues from either the animal or its fetus or newborn offspring. Infection was confirmed in postmortem tissues when N. caninum parasites were detected either by tissue cyst morphology (thick visible cyst walls) in histopathology sections, by immunoperoxidase (IPX) testing (5), or by isolation from tissues. Sera tested came from a total of 244 confirmed N. caninum-positive animals, including experimentally inoculated beef cattle (n = 21), rhesus macaque monkeys (n = 12), dogs (n = 2), rabbits (n = 2), cats (n = 2), Norway brown rats (n = 2), Swiss Webster mice (n = 68), blackbirds (n = 7), and starlings (n = 4) and naturally infected dairy cattle (n = 116), horses (n = 2), dogs (n = 4), and pygmy goats (n = 2). All sera from confirmed positive animals had elevated serum antibody titers to N. caninum as measured initially by the IFAT.
For all experimental inoculations, the tachyzoites were derived from tissue culture as described above with either Vero or cardiopulmonary aortic endothelial cells as the feeder layer. Experimentally inoculated cattle were challenged with a range of tachyzoite doses (1.5 × 106 to 8 × 107) given by various parenteral routes. All but two experimentally inoculated cows produced N. caninum-infected fetuses confirmed by IPX staining. Experimentally inoculated monkeys were challenged with 4 × 107 tachyzoites intramuscularly (i.m.) and intravenously during pregnancy as previously described (10). All monkeys produced N. caninum-infected fetuses or infants as confirmed by IPX staining and/or brain lesions plus positive precolostral serology as confirmed by IFAT. Experimentally inoculated dogs were fed canned dog food mixed with a total of 120 to 240 ml of homogenized, infected brain and spinal cord tissues from a confirmed N. caninum-infected calf. The exact parasite load found in the inoculum was undetermined, but parasites were present in both the brain and the spinal cord tissues as determined by histology. Experimentally inoculated rabbits were challenged with 1 × 106 to 8.9 × 106 tachyzoites i.m. Experimentally inoculated cats were challenged with 1.9 × 106 to 2.5 × 106 tachyzoites injected into the small intestine during ovariohysterectomy. Experimentally inoculated rats were challenged with 109 tachyzoites given orally. Experimentally inoculated blackbirds and starlings were challenged twice with 8 × 106 tachyzoites i.m. at successive 1-week intervals. Experimentally inoculated mice were challenged orally or by various parenteral routes with 8 × 104 to 5 × 106 tachyzoites (some of which were kindly provided by L. Choromanski).
Sera from naturally infected cows were taken at the time of abortion between 1991 and 1995 from animals in 11 different California dairies (3, 5). All cows had aborted N. caninum-infected fetuses as confirmed by the presence of characteristic lesions and tachyzoites in fetal tissues. Sera from naturally infected calves came from four different California dairies and were drawn within 5 days after birth. Bovine fetal fluid samples (n = 17) were collected from aborted fetuses submitted to the California Veterinary Diagnostic Laboratory System (CVDLS) at the University of California, Davis, for necropsy. All calves and fetuses were also confirmed positive for N. caninum at necropsy. Naturally infected horse samples came from two horses with equine protozoal myeloencephalitis-like symptoms that were later diagnosed with N. caninum infections based on IPX staining (16, 35). The naturally infected dogs were Rhodesian Ridgebacks that gave birth to puppies with clinical central nervous system symptoms that were confirmed as positive N. caninum infections at necropsy by IPX staining. The pygmy goat aborted an N. caninum-positive fetus as confirmed at necropsy by IPX staining.
Negative sera (n = 245) were collected from cattle (n = 56), rhesus macaque monkeys (n = 54), cats (n = 7), blackbirds (n = 14), starlings (n = 6), a budgerigar (n = 1), mice (n = 75), a rat (n = 1), pigeons (n = 10), coyotes (n = 2), and mountain lions (n = 19). The cattle were from herds with no history of N. caninum-like abortions, including beef heifers kept in a closed specific-pathogen-free herd in Nebraska, beef heifers maintained on pasture in California, and dairy cows maintained at the University of California, Davis. Five of the cows were from California dairies with an N. caninum abortion problem but had remained seronegative over a 3-year period and had produced N. caninum negative calves or had unrelated abortions with fetuses showing no signs of N. caninum infection at necropsy (5). The rhesus macaque monkeys were housed at the California Regional Primate Center on the University of California campus in Davis and had no history of N. caninum infection. Serum samples from the cats, blackbirds, starlings, budgerigars, mice, and rats were either preinoculation samples from experimentally inoculated animals or samples from contact control animals. The pigeons, coyotes, and mountain lions were necropsied at the CVDLS with no infectious disease diagnosed.
Additional negative sera (n = 58) used to evaluate the specificity of the N-MAT came from sera of animals infected with other pathogens, including rabbits (n = 4) experimentally inoculated with T. gondii (ME-49 strain), Hammondia hammondi, and Sarcocystis cruzi (32) (kindly provided by J. P. Dubey) or Sarcocystis neurona (9); cats (n = 3) experimentally inoculated orally with bradyzoites of the T-265 or T-263 strain of T. gondii (kindly provided by L. Choromanski); a mouse experimentally inoculated with S. neurona (n = 1) (36); blackbirds (n = 2) experimentally inoculated with 6 × 104 Sarcocystis falcatula merozoites i.m. or 500 S. falcatula sporocysts i.m.; budgerigars (n = 3) experimentally inoculated with S. neurona or S. falcatula (37); chickens (n = 4) experimentally inoculated with four different strains of infectious bronchitis virus; a goat (n = 1) infected with Toxoplasma (Toxoplasma DA kit [bioMerieux SA, Marcy l’Etoile, France]); horses diagnosed with S. neurona (n = 7) or an unrelated neurologic disease (n = 3); Mexican beef bulls (n = 3) with Tritrichomonas foetus infection; and bovine fetuses (n = 27) submitted to the CVDLS with no evidence of N. caninum infection but diagnosed with other diseases (bovine viral diarrhea, epizootic bovine abortion, and infectious bovine rhinotracheitis).
Determination of cutoff values.
The positive cutoff value for the ELISA was calculated at 2 standard deviations above the negative sample average. Positive cutoff values for both the N-MAT and the IFAT were determined by calculating the sensitivity, specificity, and predictive values of each test at three different titer cutoff values. The titer with the highest sensitivity and specificity results was used as the positive cutoff value. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for all three tests by the following equations: sensitivity = (number of animals both test positive and disease positive)/number of animals disease positive), specificity = (number of animals both test negative and disease negative)/(number of animals disease negative), positive predictive value = (number of animals both test positive and disease positive)/(number of animals test positive), and negative predictive value = (number of animals both test negative and disease negative)/(number of animals test negative) (50). P values were determined by running McNemar’s chi-square (χ2) test and using a standard statistical χ2 table with 1 df (38).
Measurement of reproducibility.
One hundred tests of serum from a naturally infected cow who had a history of repeat abortions were run by two different trained technicians on the IFAT and N-MAT. Results were compared between and within readers to determine reproducibility for both testing methods.
RESULTS
Cutoff values were determined with gold standard-negative (n = 76) and -positive (n = 116) naturally infected cattle samples only. A cutoff titer of 1:80 for the N-MAT gave the greatest sensitivity and specificity values. Selecting a cutoff titer lower than 1:80 resulted in decreased specificity due to increased false-positive reactions. Sensitivity significantly (P < 0.05) dropped while specificity remained the same if a cutoff value of 1:160 was used. A cutoff titer of 1:160 for the IFAT gave the greatest sensitivity and specificity values. The specificity was slightly lower at the cutoff value of 1:160 than at the 1:320 value but not enough to make up for the significant (P < 0.05) drop in sensitivity at 1:320. The mean OD of the negative samples (n = 52) used on the ELISA was 0.181 nm with a standard deviation of 0.106 nm, yielding a cutoff value at an OD of 0.393 nm.
The ELISA gave the lowest sensitivity and specificity results compared to the N-MAT and IFAT with a select group of positive (n = 63) and negative (n = 52) cattle samples (Table 1). Both the N-MAT and the IFAT gave significantly better results than the ELISA (P < 0.05), but there was no significant difference between the N-MAT and the IFAT, even though the N-MAT had a slightly higher specificity and positive predictive value.
TABLE 1.
Comparison of N-MAT, IFAT, and ELISA with selected sera from confirmed N. caninum-positive (n = 63) and -negative (n = 52) cattle
| Characteristic | Value (%) for testa
|
||
|---|---|---|---|
| N-MAT | IFAT | ELISA | |
| Sensitivity | 100 (63/63) | 100 (63/63) | 74 (47/63) |
| Specificity | 100 (52/52) | 98 (51/52) | 94 (49/52) |
| Positive predictive value | 100 (63/63) | 98 (63/64) | 94 (47/50) |
| Negative predictive value | 100 (52/52) | 100 (51/51) | 75 (49/65) |
Values in parentheses are as follows: for sensitivity, number of samples both test and disease positive/number disease positive; for specificity, number both test and disease negative/number disease negative; for positive predictive value, number both test and disease positive/number test positive; for negative predictive value, number both test and disease negative/number test negative.
Further comparison of the N-MAT and the IFAT with a larger and more diverse serum panel, including numerous animal species, revealed that, while the N-MAT gave a higher sensitivity and negative predictive value, the IFAT gave a higher specificity and positive predictive value (Table 2). These differences were not, however, statistically significant at the 5% level. When the serum panel was broken down into groups where the naturally infected-cattle, the naturally infected-other-species, and the experimentally infected-animal samples were analyzed separately (Table 3), both the N-MAT and the IFAT performed perfectly for the experimentally infected animals but gave either false-positive or false-negative results for the naturally infected-animal samples. The N-MAT gave three false-positive results in the naturally infected-cattle group and four false-positive results in the naturally infected-other-species group while the IFAT performed perfectly on the naturally infected-other-species group but gave one false-positive and three false-negative results for the naturally infected-cattle group (Table 3). The seven false-positive samples by the N-MAT were either fetal fluid samples that contained particulate matter or extensively hemolyzed serum samples from mountain lions that had been frozen and/or dead for several hours before the samples were taken. The three samples falsely negative by the IFAT were also fetal fluid samples, but the one false-positive sample was from a mature cow.
TABLE 2.
Comparison of N-MAT and IFAT with a gold standard serum panel that includes confirmed N. caninum-positive (n = 244) and -negative (n = 303) animals from 15 different species
| Characteristic | Value (%) for testa
|
|
|---|---|---|
| N-MAT | IFAT | |
| Sensitivity | 100 (244/244) | 98 (241/244) |
| Specificity | 98 (296/303) | 99 (302/303) |
| Positive predictive value | 98 (244/251) | 99 (241/242) |
| Negative predictive value | 100 (296/296) | 98 (302/305) |
Values in parentheses are as follows: for sensitivity, number of samples both test and disease positive/number disease positive; for specificity, number both test and disease negative/number disease negative; for positive predictive value, number both test and disease positive/number test positive; for negative predictive value, number both test and disease negative/number test negative.
TABLE 3.
Comparison of N-MAT and IFAT with results for naturally and experimentally infected cattle and other species within a gold standard serum panel
| Group and characteristica | Value (%) for testb
|
|
|---|---|---|
| N-MAT | IFAT | |
| Naturally infected cattle | ||
| Sensitivity | 100 (116/116) | 97 (113/116)c |
| Specificity | 96 (73/76)d | 98 (75/76) |
| Positive predictive value | 97 (116/119) | 99 (113/114) |
| Negative predictive value | 100 (73/73) | 96 (75/78) |
| Naturally infected other species | ||
| Sensitivity | 100 (8/8) | 100 (8/8) |
| Specificity | 95 (90/94)e | 100 (94/94) |
| Positive predictive value | 66 (8/12) | 100 (8/8) |
| Negative predictive value | 100 (94/94) | 100 (94/94) |
| Experimentally infected animals | ||
| Sensitivity | 100 (120/120) | 100 (120/120) |
| Specificity | 100 (133/133) | 100 (133/133) |
| Positive predictive value | 100 (120/120) | 100 (120/120) |
| Negative predictive value | 100 (133/133) | 100 (133/133) |
Naturally infected cattle are the only group that includes fetal fluids in addition to postnatal sera. Experimentally infected animals include all species.
Values in parentheses are as follows: for sensitivity, number of samples both test and disease positive/number disease positive; for specificity, number both test and disease negative/number disease negative; for positive predictive value, number both test and disease positive/number test positive; for negative predictive value, number both test and disease negative/number test negative.
3 of 17 fetal fluid samples yielded negative results from confirmed infected fetuses.
3 of 44 fetal fluid samples yielded false-positive MAT results.
Four of eight extensively hemolyzed serum samples yielded false-positive MAT results.
Had the IFAT been used as the standard test to determine the diagnostic capabilities of the N-MAT instead of histological results being used to confirm infection, both the sensitivity and the specificity of the N-MAT would have been lower (Table 4), although not significantly at the 5% level.
TABLE 4.
Comparison of N-MAT results on a gold standard serum panel with confirmed N. caninum infection and with IFAT results
| Comparison and characteristic | Value (%) for MATa |
|---|---|
| Relative to confirmed infection | |
| Sensitivity | 100 (244/244) |
| Specificity | 97 (296/303) |
| Positive predictive value | 97 (244/251) |
| Negative predictive value | 100 (296/296) |
| Relative to IFAT | |
| Sensitivity | 99 (241/242) |
| Specificity | 96 (295/305) |
| Positive predictive value | 96 (241/251) |
| Negative predictive value | 99 (295/296) |
Values in parentheses are as follows: for sensitivity, number of samples both test and disease positive/number disease positive; for specificity, number both test and disease negative/number disease negative; for positive predictive value, number both test and disease positive/number test positive; for negative predictive value, number both test and disease negative/number test negative.
In comparing the N-MAT and IFAT endpoint titers, 26% of the positive titers for the gold standard panel were in agreement. The remaining 74% were 1 to 4 dilutions off, with the N-MAT having a tendency to produce lower titers than the IFAT. Two trained readers examining 100 tests of the same positive sample were in total agreement for 41% of the tests on the N-MAT and 57% of the tests on the IFAT. The readers were within 0 to 1 dilutions of each other for 88% of the time with the N-MAT and for 95% of the time with the IFAT. Within each reader, the titers seemed to vary slightly more with the IFAT than with the N-MAT.
DISCUSSION
This is one of the first reports on the development of a serologic test for N. caninum that does not require species-specific secondary antibody conjugates. The test was adapted from the modified direct agglutination test for T. gondii (T-MAT) described by Desmonts and Remington (17), which is now marketed as the bioMerieux Toxo DA kit. While the antigen preparation techniques and testing methods are very similar, there were several adaptations, involving changes in antigen preparation, serum volume, medium, and indicator dyes.
The T. gondii antigen used in the T-MAT was prepared from parasites harvested from trypsinized sarcoma cells grown in mice, but for a simpler and more economical approach, the N. caninum antigen used in the N-MAT was prepared from parasites harvested from Vero cells grown in tissue culture. The alkaline buffer used to make the T. gondii antigen contained bovine serum albumin, but due to possible preexisting Igs from N. caninum exposure in bovine derived products, it was replaced with HS albumin for this study. False-positive results have been observed with an IFAT when antigen slides prepared with parasites maintained in medium containing fetal bovine serum were used, but switching to medium with HS eliminated the problem (6a). The N. caninum tachyzoite concentration was also higher than the T. gondii tachyzoite concentration. Desmonts and Remington (17) suggested using only 20,000 tachyzoites/μl as the antigen concentration for the T-MAT; however, the optimal antigen concentration for the N-MAT was found to be no less than 30,000 and no more than 40,000 tachyzoites/μl. If the concentration of the tachyzoites in the antigen was too low, reactions were not detectable. Conversely, if the antigen concentration was too high, the negative buttons began to appear fuzzy, looking more like weakly positive reactions than like true-negative reactions, and resulted in false-positive readings.
As stated by Desmonts and Remington (17) for the T. gondii antigen, preservation of the parasite integrity and reduction of cell culture debris in the antigen preparation were very important for the N. caninum antigen to work properly. The parasites had to retain a normal crescent shape to maintain optimum test sensitivity, and as a result, tachyzoite preparations could not be passed through a needle to break up intact cells, could not be frozen for later use, and could not be filtered through a 5-μm-pore-size filter. The parasites had to be drawn through a special column (Pharmacia Biotech) that reduced cell debris without decreasing parasite numbers or disturbing the tachyzoite morphology. This requirement for undisturbed N. caninum tachyzoites strongly suggests that an intact cell membrane is necessary for accurate N-MAT results. It also suggests that significant parasite-specific antigen epitopes are present on the outer parasitic membrane but that nonspecific antigens that cross-react with other related parasites are present within the parasitic cytoplasm and are exposed following the rupture of the tachyzoite cell membrane. Similar findings have been reported by Williams et al. (51) and Bjorkman et al. (13) in dealing with cross-reactivity problems of an N. caninum ELISA.
The bioMerieux Toxo DA kit uses an initial serum volume of 100 μl to prepare serial dilutions for running the test. With the N-MAT, we found that only 5 μl of each serum sample was sufficient to prepare dilutions without compromising the test results. The T-MAT kit also has a dye (name not given) added to the alkaline buffer that stains the negative pellet and makes the test easier to read and more reproducible. However, when the dye used in the bioMerieux Toxo DA kit was used in the N-MAT, the parasites did not stain adequately. Up to 15 different dyes were tested in an effort to find one that would work. Eosin Y gave the best results, although it did not stain the N. caninum pellets as distinctly as the T. gondii pellets were stained in the bioMerieux Toxo DA kit. Overall, when the N-MAT was compared to the T-MAT, the T. gondii agglutination reactions were more distinct and easier to read. This may be due to differences in the major surface proteins between the two parasites (12, 30). In addition, results from the T-MAT kit could be read after letting the test plate sit at room temperature undisturbed for 5 h, but the N-MAT results were readable only after an overnight incubation, which remains the only major drawback to this test.
The determined cutoff values established for the N-MAT, Neospora IFAT, and ELISA in this study were comparable to what others have suggested for T-MAT and Neospora IFAT and ELISA (24, 26, 43, 46). Dubey et al. (24) arbitrarily selected a cutoff of 1:25 for the T-MAT, although Thulliez (46) found that the specificity of the agglutination reaction was optimal at 1:40 and that the test started to give false-positive results below this dilution. Our results indicate that the highest sensitivity and specificity were obtained for the N-MAT at a cutoff value of 1:80. These various chosen cutoff values may be one of the reasons that Dubey et al. obtained a lower specificity (90%) with the T-MAT (24) than we did with the N-MAT in this study (98%). Selection of differing cutoff values would also partially explain reported sensitivity differences for the N. caninum IFAT. Paré et al. (43) reported a sensitivity of 77% for their N. caninum IFAT with a cutoff value of 1:640, while our sensitivity was 98% with a chosen cutoff value of 1:160. Data from another study comparing the IFAT to an immunostimulating complex iscom) ELISA approximates our reported 98% sensitivity for the IFAT (13). The cutoff value for the N. caninum ELISA developed by Dubey et al. (26) was at an OD value of 0.40 nm, which was very close to the cutoff OD value in this study at 0.39 nm.
Compared to the N. caninum ELISA and IFAT, the N-MAT produced the highest sensitivity (Tables 1 and 2), which is consistent with other reports comparing the T-MAT to the T. gondii ELISA (24, 44) and IFAT (29, 44). Comparisons of the T-MAT to other T. gondii serologic tests have shown it to be more sensitive than the dye test (17, 22–24), latex agglutination test (22–25), and indirect hemagglutination test (22–25) as well. However, the N-MAT did have a lower specificity compared to that of the N. caninum IFAT, which is also similar to reports on the T-MAT (24, 29). The N. caninum ELISA used in this study had a significantly lower sensitivity and specificity than both the N-MAT and the IFAT, which might be expected with a whole-parasite lysate, although higher values have been reported with a similar whole-parasite lysate ELISA (42). Low sensitivity and specificity values for the whole-parasite lysate ELISAs would not be unexpected since parasite lysis would lead to the release of numerous cytoplasmic antigens, including nonspecific group antigens for the Apicomplexa. Further, as stated above, our studies with the N-MAT do suggest that nonspecific reactions may be associated more with internal parasitic antigens than with surface antigens. More recently developed second-generation ELISAs give greatly improved sensitivities and specificities; however, they are still lower than the N-MAT and IFAT values for N. caninum in this study. These second-generation ELISAs rely on the selection of single N. caninum-specific antigens or groups of specific antigens. Such tests include the iscom ELISA (13), the intact formalin-fixed N. caninum ELISA (51), and the recombinant N. caninum ELISA (31, 34).
The sensitivities and specificities of the N-MAT among different groups of animals are summarized in Table 3. The test was highly sensitive for all groups of animals, but the specificity was reduced in naturally, versus experimentally, infected animals. This might be due to cross-reacting antibodies from exposure to closely related but unknown members of the Apicomplexa that have shared antigen epitopes. However, when animals with known infections with closely related apicomplexan parasites were tested by the N-MAT in this study, no cross-reactivity was observed. Therefore, another possible explanation for this variability between experimental and natural infections is the difference in the time course of infection. The experimental animals invariably had acute or recent infections compared to those of the naturally infected animals, many of which were chronically infected. Further, our definition for infection may be too stringent and thus biased. In this study, the definition of infected required confirmation of infection by the presence of lesions or organisms but ignored the possibility of animals having latent, undetected natural infection or exposure. Finally, the serum collected from animals with experimental infections was in optimal condition compared to that from the naturally infected animals. False-positive results were increased as a result, especially with severely hemolyzed sera or fetal fluid samples (Table 3).
The naturally infected-cattle and the naturally infected-other-species groups (Table 3) had similar sensitivities and specificities when tested by the N-MAT, but the positive predictive value was greatly reduced in the naturally infected-other-species group due to low numbers of confirmed infections in this group (Table 3). Results from a much larger sample size for each species would allow for increased positive predictive values and confidence intervals.
The IFAT actually performed better overall for the naturally infected-other group than for the naturally infected-cattle group. This disparity may be a reflection of small sample size in the naturally infected-other group (Table 3). Additionally, it may be an artifact resulting from our working definition of positive within the group of N. caninum-infected bovine fetuses tested. Within this bovine fetal group, three histologically confirmed infected fetuses tested negative for antibodies to N. caninum by the IFAT but positive by the N-MAT. We chose to include these as positives since they had confirmed infections by histology; however, this may be incorrect since the production of fetal N. caninum antibodies requires the infected fetus to be sufficiently developed enough to have a mature immune system (∼130 to 145 days of gestation) and to remain viable long enough to produce antibodies (11, 43). Studies with the IFAT have shown that a lack of specific fetal titer to N. caninum does not rule out fetal neosporosis, especially for those fetuses younger than 6 months of gestation (11). Alternatively, the T-MAT is known for detecting very low amounts of antibodies, and therefore, it is possible that the same holds true for the N-MAT, which might detect a fetal antibody response earlier than the IFAT (17, 24, 33, 44). In this case, either the N-MAT gave three more false-positive results on fetal fluid samples because the fetuses were too young to mount an immune response or the fetuses were just old enough to start their immune response and the N-MAT was able to detect the small amount of antibodies earlier than could the IFAT. Either way, all fetal infections should be further examined by histological methods to confirm results.
Overall, the N-MAT developed in this study is rapid, highly sensitive, and easy to use and would be ideal for screening large numbers of wildlife or domestic animal samples for the presence of N. caninum antibodies. The test can be used on hemolyzed sera with the understanding that false-positive results are more likely on severely hemolyzed sera. Positive results on such samples must be further confirmed as positive by more conventional methodologies (histology, PCR, etc.). The N-MAT allows for the determination of N. caninum seroprevalence in wildlife populations without requiring species-specific conjugates and could aid in the search for and discovery of a definitive host. Up to 16 different species were tested on this newly developed N. caninum agglutination test, which demonstrates its ability to effectively screen samples from a wide variety of species. Continued use of the N-MAT to screen a large number of samples from as many different species as possible may help researchers to target those species which have a greater probability of being exposed to N. caninum and possibly being the definitive host.
ACKNOWLEDGMENTS
This research was funded in part by USDA Formula Funds and a grant from the Large Animal Disease Research Laboratory of the University of California, Davis.
Special thanks to Linda Smith and Leszek Choromanski from the Bayer Corporation, the California Regional Primate Center, the Center for Equine Health, and J. P. Dubey for providing serum samples. We also thank Lisa Tell and Kirsten Dahl for their expertise and assistance with the captive birds.
REFERENCES
- 1.Abbitt B, Craig T M, Jones L P, Huey R L, Eugster A K. Protozoal abortion in a herd of cattle concurrently infected with Hammondia pardalis. J Am Vet Med Assoc. 1993;203:444–448. [PubMed] [Google Scholar]
- 2.Anderson M L, Blanchard P C, Barr B C, Dubey J P, Hoffman R L, Conrad P A. Neospora-like protozoan infection as a major cause of abortion in California dairy cattle. J Am Vet Med Assoc. 1991;198:241–244. [PubMed] [Google Scholar]
- 3.Anderson M L, Palmer C W, Thurmond M C, Picanso J P, Blanchard P C, Breitmeyer R E, McAllister M, Daft B, Kinde H, Read D H, Dubey J P, Conrad P A, Barr B C. Evaluation of abortion in cattle attributed to neosporosis in selected dairies in California. J Am Vet Med Assoc. 1995;207:1206–1210. [PubMed] [Google Scholar]
- 4.Anderson M L, Barr B C, Rowe J D, Sverlow K W, Packham A E, Conrad P A. Neosporosis and abortion in dairy cattle. Proc West Can Dairy Semin Adv Dairy Technol. 1996;8:197–209. [Google Scholar]
- 5.Anderson M L, Reynolds J P, Rowe J D, Sverlow K W, Packham A E, Barr B C, Conrad P A. Evidence of vertical transmission of Neospora sp. infection in dairy cattle. J Am Vet Med Assoc. 1997;210:1169–1172. [PubMed] [Google Scholar]
- 6.Aubert D, Foudrinier F, Kaltenbach M L, Guyot-Walser D, Marx-Chemla C, Geers R, Lepan H, Pinon J M. Automated reading and processing of quantitative IgG, IgM, IgA, and IgE isotypic agglutination results in microplates: development and application in parasitology-mycology. J Immunol Methods. 1995;186:323–328. doi: 10.1016/0022-1759(95)00162-4. [DOI] [PubMed] [Google Scholar]
- 6a.Barr, B. Personal communication.
- 7.Barr B C, Conrad P A, Dubey J P, Anderson M L. Neospora-like encephalomyelitis in a calf: pathology, ultrastructure, and immunoreactivity. J Vet Diagn Invest. 1991;3:39–46. doi: 10.1177/104063879100300109. [DOI] [PubMed] [Google Scholar]
- 8.Barr B C, Conrad P A, Breitmeyer R, Sverlow K W, Anderson M L, Reynolds J, Chauvet A E, Dubey J P, Ardans A A. Congenital Neospora infection in calves born from cows that had previously aborted Neospora-infected fetuses: four cases (1990–1992) J Am Vet Med Assoc. 1993;202:113–117. [PubMed] [Google Scholar]
- 9.Barr B C, Rowe J D, Sverlow K W, BonDurant R H, Ardans A A, Oliver M N, Conrad P A. Experimental reproduction of bovine fetal Neospora infection and death with a bovine Neospora isolate. J Vet Diagn Invest. 1994;6:207–215. doi: 10.1177/104063879400600212. [DOI] [PubMed] [Google Scholar]
- 10.Barr B C, Conrad P A, Sverlow K W, Tarantal A F, Hendrickx A G. Experimental fetal and transplacental Neospora infection in the nonhuman primate. Lab Invest. 1994;71:236–242. [PubMed] [Google Scholar]
- 11.Barr B C, Anderson M L, Sverlow K W, Conrad P A. Diagnosis of bovine fetal Neospora infection with an indirect fluorescent antibody test. Vet Rec. 1995;137:611–613. [PubMed] [Google Scholar]
- 11a.Barr, B. C., and P. A. Conrad. Unpublished data.
- 12.Bjerkas I, Jenkins M C, Dubey J P. Identification and characterization of Neospora caninum tachyzoite antigens useful for diagnosis of neosporosis. Clin Diagn Lab Immunol. 1994;1:214–221. doi: 10.1128/cdli.1.2.214-221.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Björkman C, Lundén A, Holmdahl J, Barber J, Trees A J, Uggla A. Neospora caninum in dogs: detection of antibodies by ELISA using an iscom antigen. Parasite Immunol. 1994;16:643–648. doi: 10.1111/j.1365-3024.1994.tb00320.x. [DOI] [PubMed] [Google Scholar]
- 14.Conrad P A, Sverlow K W, Anderson M A, Rowe J D, BonDurant R, Tuter G, Breitmeyer R, Palmer C, Thurmond M, Ardans A A, Dubey J P, Duhamel G, Barr B. Detection of serum antibody responses in cattle with natural or experimental Neospora infections. J Vet Diagn Invest. 1993;5:572–578. doi: 10.1177/104063879300500412. [DOI] [PubMed] [Google Scholar]
- 15.Conrad P A, Barr B C, Sverlow K W, Anderson M, Daft B, Kinde H, Dubey J P, Munson L, Ardans A. In vitro isolation and characterization of Neospora sp. from aborted bovine foetuses. Parasitology. 1993;106:239–249. doi: 10.1017/s0031182000075065. [DOI] [PubMed] [Google Scholar]
- 16.Daft B M, Barr B C, Collins N, Sverlow K W. Neospora encephalomyelitis and polyradiculoneuritis in an aged mare with Cushing’s disease. Equine Vet J. 1997;29:240–243. doi: 10.1111/j.2042-3306.1997.tb01678.x. [DOI] [PubMed] [Google Scholar]
- 17.Desmonts G, Remington J S. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol. 1980;11:562–568. doi: 10.1128/jcm.11.6.562-568.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dubey J P. A review of Neospora caninum and Neospora-like infections in animals. J Protozool. 1992;2:40–52. [Google Scholar]
- 19.Dubey J P. Letter. J Am Vet Med Assoc. 1993;203:1250–1251. [PubMed] [Google Scholar]
- 20.Dubey J P, Carpenter J L, Speer C A, Topper M J, Uggla A. Newly recognized fatal protozoan disease of dogs. J Am Vet Med Assoc. 1988;192:1269–1285. [PubMed] [Google Scholar]
- 21.Dubey J P, Hattel A L, Lindsay D S, Topper M J. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc. 1988;193:1259–1263. [PubMed] [Google Scholar]
- 22.Dubey J P, Thulliez M D. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. J Am Vet Med Assoc. 1989;109:1297–1299. [PubMed] [Google Scholar]
- 23.Dubey J P, Goodwin M A, Ruff M D, Kwok O C H, Shen S K, Wilkins G C, Thulliez P. Experimental toxoplasmosis in Japanese quail. J Vet Diagn Invest. 1994;6:216–221. doi: 10.1177/104063879400600213. [DOI] [PubMed] [Google Scholar]
- 24.Dubey J P, Thulliez P, Weigel R M, Andrews C D, Lind P, Powell E C. Sensitivity and specificity of various serologic tests for detection of Toxoplasma gondii infection in naturally infected sows. Am J Vet Res. 1995;56:1030–1036. [PubMed] [Google Scholar]
- 25.Dubey J P, Andrews C D, Lind P, Kwok O C H, Thulliez P, Lunney J K. Antibody responses measured by various serologic tests in pigs orally inoculated with low numbers of Toxoplasma gondii oocysts. Am J Vet Res. 1996;57:1733–1737. [PubMed] [Google Scholar]
- 26.Dubey J P, Lindsay D S, Adams D S, Gay J M, Baszler T V, Blagburn B L, Thulliez P. Serologic responses of cattle and other animals infected with Neospora caninum. Am J Vet Res. 1996;57:329–336. [PubMed] [Google Scholar]
- 27.Fulton J D. Micro-agglutination test for Toxoplasma antibodies. Immunology. 1965;9:491–495. [PMC free article] [PubMed] [Google Scholar]
- 28.Fulton J D, Turk J L. Direct agglutination test for Toxoplasma gondii. Lancet. 1959;ii:1068–1069. doi: 10.1016/s0140-6736(59)91535-1. [DOI] [PubMed] [Google Scholar]
- 29.Fulton J D, Voller A. Evaluation of immunofluorescent and direct agglutination methods for detection of specific Toxoplasma antibodies. Br Med J. 1964;2:1173–1175. doi: 10.1136/bmj.2.5418.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hemphill A, Gottstein B. Identification of a major surface protein on Neospora caninum tachyzoites. Parasitol Res. 1996;82:497–504. doi: 10.1007/s004360050152. [DOI] [PubMed] [Google Scholar]
- 31.Lally N C, Jenkins M C, Dubey J P. Evaluation of two Neospora caninum recombinant antigens for use in an enzyme-linked immunosorbent assay for the diagnosis of bovine neosporosis. Clin Diagn Lab Immunol. 1996;3:275–279. doi: 10.1128/cdli.3.3.275-279.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lindsay D S, Dubey J P. Immunohistochemical diagnosis of Neospora caninum in tissue sections. Am J Vet Res. 1989;50:1981–1983. [PubMed] [Google Scholar]
- 33.Ljungstrom B L, Lunden A, Hoglund J, Zakrisson G. Evaluation of a direct agglutination test for detection of antibodies against Toxoplasma gondii in cat, pig and sheep sera. Acta Vet Scand. 1994;35:213–216. doi: 10.1186/BF03548349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Louie K, Sverlow K W, Barr B C, Anderson M L, Conrad P A. Cloning and characterization of two recombinant Neospora protein fragments and their use in serodiagnosis of bovine neosporosis. Clin Diagn Lab Immunol. 1997;4:692–699. doi: 10.1128/cdli.4.6.692-699.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Marsh A E, Barr B C, Madigan J, Lakaritz J, Nordhausen R, Conrad P A. Neosporosis as a cause of equine protozoal myeloencephalitis. J Am Vet Med Assoc. 1996;209:1907–1913. [PubMed] [Google Scholar]
- 36.Marsh A E, Barr B C, Lakritz J, Nordhausen R, Madigan J E, Conrad P A. Experimental infection of nude mice as a model for Sarcocystis neurona associated encephalitis. Parasitol Res. 1997;83:706–711. doi: 10.1007/s004360050323. [DOI] [PubMed] [Google Scholar]
- 37.Marsh A E, Barr B C, Tell L, Greiner E, Dame J, Conrad P A. In vitro cultivation and experimental inoculation of Sarcocystis falcatula and Sarcocystis neurona merozoites into budgerigars (Melopsittacus undulatus) J Parasitol. 1997;83:1189–1192. [PubMed] [Google Scholar]
- 38.Martin S W, Meek A H, Willeberg P. Veterinary epidemiology: principles and methods. Ames: Iowa State University Press; 1987. pp. 126–127. [Google Scholar]
- 39.McAllister M M. Letter. J Am Vet Med Assoc. 1993;203:1251. [PubMed] [Google Scholar]
- 40.McAllister M M, Huffman E M, Hietala S K, Conrad P A, Anderson M L, Salman M D. Evidence suggesting a point source exposure in an outbreak of bovine abortion due to neosporosis. J Vet Diagn Invest. 1996;8:355–357. doi: 10.1177/104063879600800313. [DOI] [PubMed] [Google Scholar]
- 41.Obendorf D L, Statham P, Driessen M. Detection of agglutinating antibodies to Toxoplasma gondii on sera from free-ranging eastern barred bandicoots (Perameles gunnii) J Wildl Dis. 1996;32:623–626. doi: 10.7589/0090-3558-32.4.623. [DOI] [PubMed] [Google Scholar]
- 42.Paré J, Hietala S K, Thurmond M C. An enzyme-linked immunosorbent assay (ELISA) for serological diagnosis of Neospora infection in cattle. J Vet Diagn Invest. 1995;7:352–359. doi: 10.1177/104063879500700310. [DOI] [PubMed] [Google Scholar]
- 43.Paré J, Hietala S K, Thurmond M C. Interpretation of an indirect fluorescent antibody test for diagnosis of Neospora sp. infection in cattle. J Vet Diagn Invest. 1995;7:273–275. doi: 10.1177/104063879500700222. [DOI] [PubMed] [Google Scholar]
- 44.Seefeldt S L, Kirkbride C A, Dubey J P. Comparison of enzyme-linked immunosorbent assay, indirect fluorescent antibody test, and direct agglutination test for detecting Toxoplasma gondii antibodies in naturally aborted ovine fetuses. J Vet Diagn Invest. 1989;1:124–127. doi: 10.1177/104063878900100206. [DOI] [PubMed] [Google Scholar]
- 45.Thornton R A, Thompson E J, Dubey J P. Neospora abortion in New Zealand cattle. N Z Vet J. 1991;39:129–133. doi: 10.1080/00480169.1991.35679. [DOI] [PubMed] [Google Scholar]
- 46.Thulliez P. Toxoplasmosis diagnosis. Marcy l’Etoile, France: bioMerieux; 1995. ISAGA/SDA: reference tests; pp. 19–21. [Google Scholar]
- 47.Thurmond M C, Hietala S K. Culling associated with Neospora caninum infection in dairy cows. Am J Vet Res. 1996;57:1559–1562. [PubMed] [Google Scholar]
- 48.Thurmond M C, Hietala S K, Blanchard P C. Herd-based diagnosis of Neospora caninum-induced endemic and epidemic abortion in cows and evidence for congenital and postnatal transmission. J Vet Diagn Invest. 1997;9:44–49. doi: 10.1177/104063879700900108. [DOI] [PubMed] [Google Scholar]
- 49.Trees A J, Guy F, Low J C, Roberts L, Buxton D, Dubey J P. Serological evidence implicating Neospora species as a cause of abortion in British cattle. Vet Rec. 1994;134:405–407. doi: 10.1136/vr.134.16.405. [DOI] [PubMed] [Google Scholar]
- 50.Tyler J W, Cullor J S. Titers, tests, and truisms: rational interpretation of diagnostic serologic testing. J Am Vet Med Assoc. 1989;194:1550–1558. [PubMed] [Google Scholar]
- 51.Williams D J, McGarry J, Guy F, Barber J, Trees A J. Novel ELISA for detection of Neospora-specific antibodies in cattle. Vet Rec. 1997;140:328–331. doi: 10.1136/vr.140.13.328. [DOI] [PubMed] [Google Scholar]
- 52.Wilson M, Ware D A, Juranek D D. Serologic aspects of toxoplasmosis. J Am Vet Med Assoc. 1990;196:277–281. [PubMed] [Google Scholar]
- 53.Wouda W, van den Ingh T S, van Knapenl F, Sluyter F J, Koeman J P, Dubey J P. Bovine abortion due to Neospora in the Netherlands. Tijdschr Diergeneeskd. 1992;117:599–602. [PubMed] [Google Scholar]
- 54.Yaeger M J, Shawd-Wessels S, Leslie-Steen P. Neospora abortion storm in a Midwestern dairy. J Vet Diagn Invest. 1994;6:506–508. doi: 10.1177/104063879400600424. [DOI] [PubMed] [Google Scholar]